Donate To Research Join The AAN

Events

Resources For

Abstract Details

Title MS Arising During Tocilizumab Therapy for Rheumatoid Arthritis

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 014

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Philippe Beauchemin, MD PRESENTER	Dr. Beauchemin has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Dr. Beauchemin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche Canada. Dr. Beauchemin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Beauchemin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Canada. Dr. Beauchemin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pendopharm. Dr. Beauchemin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Beauchemin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Robert L. Carruthers, MD	Dr. Carruthers has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Carruthers has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche and Genentech. The institution of Dr. Carruthers has received research support from Roche and Genentech .